Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finke

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
Blood|August 8, 1998
Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalphaW Ling, P Rayman, R Uzzo, et al.
Bone Marrow Transplantation|August 1, 1996
Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimenC F Waller, H Bertz, M K Wenger, et al.
Bone Marrow Transplantation|March 7, 2003
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrowL Garderet, M Labopin, N C Gorin, et al.
Immunopharmacology and Immunotoxicology|January 27, 2006
Attempted passive prophylaxis with a monoclonal anti-Burkholderia pseudomallei exopolysaccharide antibody in a murine model of melioidosisChantal Bottex, Yves P Gauthier, Ralf M Hagen, et al.
Bone Marrow Transplantation|September 20, 2016
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMTS Eder, M Labopin, J Finke, et al.
Cancer Research|October 15, 1994
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary reportX Li, J Liu, J K Park, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
British Journal of Haematology|November 25, 2000
Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulinJ Finke, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|November 1, 2020
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
Blood|August 8, 1998
Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalphaW Ling, P Rayman, R Uzzo, et al.
Bone Marrow Transplantation|August 1, 1996
Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimenC F Waller, H Bertz, M K Wenger, et al.
Bone Marrow Transplantation|March 7, 2003
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrowL Garderet, M Labopin, N C Gorin, et al.
Immunopharmacology and Immunotoxicology|January 27, 2006
Attempted passive prophylaxis with a monoclonal anti-Burkholderia pseudomallei exopolysaccharide antibody in a murine model of melioidosisChantal Bottex, Yves P Gauthier, Ralf M Hagen, et al.
Bone Marrow Transplantation|September 20, 2016
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMTS Eder, M Labopin, J Finke, et al.
Cancer Research|October 15, 1994
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary reportX Li, J Liu, J K Park, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
British Journal of Haematology|November 25, 2000
Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulinJ Finke, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|November 1, 2020
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Pageof 27